Is cabozantinib available in China? Is it easy to buy?

Cabotinib is a multi-target tyrosine kinase inhibitor mainly used to treat malignant tumors such as thyroid cancer, renal cell carcinoma and liver cancer. This article will conduct a detailed discussion from three aspects: whether cabozantinib is available in China, whether the purchase channel is convenient, and whether it is included in the national medical insurance, to help patients better understand the accessibility and economics of this drug.

Is cabozantinib available on the market in China

is an important anti-cancer drug, and its launch in the Chinese market has attracted much attention. The following is specific information about the launch of cabozantinib in China.

Time to market

Cabozantinib will be officially approved for marketing in China in 2021. The approval was based on data from multiple international clinical trials demonstrating significant efficacy in the treatment of advanced thyroid cancer, renal cell carcinoma and liver cancer. The launch in China provides new treatment options for domestic patients.

Scope of indications

In China, cabozantinib’s approved indications include advanced thyroid cancer, renal cell carcinoma and liver cancer. These indications are basically consistent with the internationally approved scope and meet the needs of domestic patients. Doctors will decide whether to use cabozantinib based on the patient's specific condition.

Domestic production and import

Currently, cabozantinib is mainly supplied in the Chinese market as an import, produced and distributed by international pharmaceutical companies. There are no generic drugs on the market in China yet, so patients use original drugs.

The launch of cabozantinib in China provides patients with an important treatment option, but its price is relatively high, and patients need to choose an appropriate treatment plan based on their own economic conditions.

Is cabozantinib easy to buy?

As a prescription drug, cabozantinib’s purchase channels and convenience are crucial to patients.

Purchase in hospital pharmacies

Cabozantinib can be purchased in pharmacies of large tertiary hospitals in China. Patients need to purchase it with a prescription issued by a doctor. Because cabozantinib is a specially managed drug, some hospitals may need to make an appointment or transfer the goods in advance.

Online drug purchasing platforms

Some formal online drug purchasing platforms also provide cabozantinib sales services. Patients can upload prescriptions through the platform and purchase drugs after review. The advantages of online drug purchasing platforms are transparent prices and convenient delivery, but you need to choose a qualified platform to avoid the risk of counterfeit drugs.

Overseas drug purchase channels

For some patients who cannot purchase cabozantinib domestically, overseas drug purchase is an option. Patients can purchase drugs through regular overseas medical intermediaries or cross-border drug purchasing platforms, but they need to pay attention to the authenticity of the drugs and the storage conditions during transportation.

The purchasing channels for cabozantinib are relatively diverse, and patients can choose the most convenient method according to their own circumstances. No matter which channel you purchase, you need to ensure that the source of the medicine is legal.

Is cabozantinib included in the national medical insurance?

The price of cabozantinib is relatively high, and whether it is included in the national medical insurance is directly related to the financial burden of the patient. Below is specific information about Medicare coverage for cabozantinib.

Time for inclusion in medical insurance

Cabozantinib will be included in the national medical insurance directory in 2022, reducing the financial pressure on patients and enabling more patients to afford this important anti-cancer drug.

Medical insurance reimbursement ratio

The medical insurance reimbursement ratio of cabozantinib varies from region to region, and is usually between 50% and 70%. Patients need to understand the specific reimbursement ratio and process based on local medical insurance policies. Special medical insurance policies in some areas may provide higher reimbursement ratios.

Restrictions on use by medical insurance

Although cabozantinib has been included in medical insurance, its use still needs to comply with the indications and conditions stipulated by medical insurance. Patients must use it under the guidance of a doctor and provide relevant diagnosis certificates and prescriptions to enjoy medical insurance reimbursement.

The launch, convenience of purchase and medical insurance coverage of cabozantinib in China provide patients with comprehensive treatment support. When using it, patients should choose the most appropriate treatment plan and drug purchasing channels based on their own conditions.